Betoact Eye Drops 1.5% (5ml)
Out Of Stock
|US Brand Name||Bepreve|
|Manufacturer||Ajanta Pharma, India|
Betoact eye drop contains Bepotastine besilate ophthalmic solution 1.5%, is a histamine H1 receptor antagonist, and is used to treat itching associated with allergic rhinitis symptoms. The active ingredient Bepotastine besilate acts by blocking the action of chemical messenger histamine, which is responsible for itchy, red, and watery eyes. For best results, one drop of eye medication twice a day. Remove contact lenses before the instillation of this eye medication.
Follow your doctor’s instructions precisely for administering Betoact eye solution in the eye. It should be used as advised by your doctor. Betoact eye drops are effective in the dose and duration advised by the doctor. Take it exactly as directed without skipping the application. Stick to your doctor’s advice and let your doctor know if you experience any bothersome effects.
Do not skip the application and finish the full course of treatment even if you feel better. The product is safe to use during pregnancy and breastfeeding. Patients should be advised not to wear contact lens if their eye is red. The ophthalmic formulation is not effective in treating contact lens-related irritation.
Before using Bepotastine topical therapy, you should tell your doctor if you are allergic to Betoact eye drop 1.5% (5ml) or any of its ingredients to avoid allergic reactions. Let your ophthalmologist know if you have ever had an eye problem. Also, inform your doctor about all the topical therapies and oral treatments you are using because they may affect or affect this eye medication.
To minimize contaminating the dropper tip and ophthalmic solution, advise the patient not to touch the eyelids or surrounding areas with the bottle’s tip and keep the bottle tightly closed when not in use.
Betoact eye drop should not be used to treat contact lens-related irritation. It should be instilled while wearing contact lenses. Patients are advised to remove their contact lenses before Betoact administration because the eye drop has benzalkonium chloride that soft lenses may absorb. Contact lenses may be reinserted after ten minutes following administration of Bepotastine besilate.
The safety and effectiveness of Betoact 1.5% have not been established in paediatric patients under two years of age.
Common side effects of Betoact eye drop 1.5% (5ml) seen with this medicine include eye irritation, headache, and nasopharyngitis. Speak to your doctor if these side effects persist for a longer duration or if your condition worsens. However, most side effects do not require medical attention and disappear as your body adjusts to the medicine. Its regular use may cause burring of your vision for a short time just after its use. Therefore, avoid driving or indulge in activities that require you to be alert.